-
Mashup Score: 0Alerts | American Association for Cancer Research - 29 day(s) ago
Alerts | American Association for Cancer Research .main-content h1 { font-weight: 300; color: #44b13e; margin-bottom: 0; } .main-content h3 { margin-bottom: 16px; } .main-content h3 a{ color: rgb(76, 167, 68); } .main-content h3 a{ margin-bottom: 12px; } .main-content div img{ float: left; margin: 0 16px 12px 0; } .main-content div ul { list-style-image: url(‘/ImageLibrary/umbrella/icons/Pubs_bullet.png’); list-style-position: inside; }…
Source: aacrjournals.orgCategories: General Medicine NewsTweet
-
Mashup Score: 0Alerts | American Association for Cancer Research - 2 month(s) ago
Alerts | American Association for Cancer Research .main-content h1 { font-weight: 300; color: #44b13e; margin-bottom: 0; } .main-content h3 { margin-bottom: 16px; } .main-content h3 a{ color: rgb(76, 167, 68); } .main-content h3 a{ margin-bottom: 12px; } .main-content div img{ float: left; margin: 0 16px 12px 0; } .main-content div ul { list-style-image: url(‘/ImageLibrary/umbrella/icons/Pubs_bullet.png’); list-style-position: inside; }…
Source: aacrjournals.orgCategories: General Medicine NewsTweet-
Stay up to date by signing up for Cancer Discovery News Alerts: https://t.co/DG8VFp6ztu https://t.co/sAkLqXkrmH
-
-
Mashup Score: 3CD News | American Association for Cancer Research - 2 month(s) ago
A new targeted therapy aimed specifically at FGFR3, TYRA-300, is showing preliminary promise in patients with advanced FGFR3 -altered bladder cancer. Partial responses have been seen in an ongoing phase I trial, and the drug is much better tolerated than erdafitinib, a pan–FGFR inhibitor and an … According to research presented at the Society for the Immunotherapy of Cancer Annual Meeting in Houston, TX, the IL15 agonist NKTR-255 (Nektar Therapeutics) reverses lymphopenia caused by chemoradiation
Source: aacrjournals.orgCategories: General Medicine News, Onc News and JournalsTweet-
Cancer Discovery News: Highlighting Must-Read Industry News. https://t.co/NMuT4XEvTo https://t.co/cLIAqwagBp
-
-
Mashup Score: 0Alerts | American Association for Cancer Research - 2 month(s) ago
Alerts | American Association for Cancer Research .main-content h1 { font-weight: 300; color: #44b13e; margin-bottom: 0; } .main-content h3 { margin-bottom: 16px; } .main-content h3 a{ color: rgb(76, 167, 68); } .main-content h3 a{ margin-bottom: 12px; } .main-content div img{ float: left; margin: 0 16px 12px 0; } .main-content div ul { list-style-image: url(‘/ImageLibrary/umbrella/icons/Pubs_bullet.png’); list-style-position: inside; }…
Source: aacrjournals.orgCategories: General Medicine NewsTweet-
Stay up to date by signing up for Cancer Discovery News Alerts: https://t.co/DG8VFp6ztu https://t.co/sAkLqXkrmH
-
-
Mashup Score: 22Glioblastoma Cortical Organoids Recapitulate Cell-State Heterogeneity and Intercellular Transfer - 3 month(s) ago
Glioblastoma-cortical organoids recreate intercellular mRNA transfer between heterogeneous cell populations, providing a scalable platform for interrogating state-specific communication dynamics in glioblastoma.
Source: aacrjournals.orgCategories: General Medicine NewsTweet-
From the February issue: #Glioblastoma-Cortical #Organoids Recapitulate Cell State Heterogeneity and Intercellular Transfer https://t.co/TjN49ShbBk By Vamsi Mangena, @RChanoch, Paola Arlotta, @tiroshlab, @MarioSuva, and colleagues @broadinstitute @weizmannscience @MGHCancerCenter https://t.co/kb0UfLeROX
-
-
Mashup Score: 12025 Professional Development Session “Productive Peer Review: Improving Science while Avoiding Common Pitfalls” Registration - 3 month(s) ago
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Source: www.surveymonkey.comCategories: General Medicine NewsTweet-
Attending the @AACR Annual Meeting? Register for “Productive Peer Review: Improving Science while Avoiding Pitfalls” on 4/28. Drs. Iacobuzio-Donahue & Lovly will moderate the interactive Professional Advancement Session. https://t.co/czWFdzMpc4 @ciacobu @christine_lovly #AACR25 https://t.co/Wkvxs9HG4Y
-
-
Mashup Score: 3CD News | American Association for Cancer Research - 3 month(s) ago
A new targeted therapy aimed specifically at FGFR3, TYRA-300, is showing preliminary promise in patients with advanced FGFR3 -altered bladder cancer. Partial responses have been seen in an ongoing phase I trial, and the drug is much better tolerated than erdafitinib, a pan–FGFR inhibitor and an … According to research presented at the Society for the Immunotherapy of Cancer Annual Meeting in Houston, TX, the IL15 agonist NKTR-255 (Nektar Therapeutics) reverses lymphopenia caused by chemoradiation
Source: aacrjournals.orgCategories: General Medicine News, Onc News and JournalsTweet-
Cancer Discovery News: Highlighting Must-Read Industry News. https://t.co/NMuT4XEvTo https://t.co/cLIAqwagBp
-
-
Mashup Score: 12025 Professional Development Session “Productive Peer Review: Improving Science while Avoiding Common Pitfalls” Registration - 3 month(s) ago
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Source: www.surveymonkey.comCategories: General Medicine NewsTweet-
Attending the @AACR Annual Meeting? Register for “Productive Peer Review: Improving Science while Avoiding Pitfalls” on 4/28. Drs. Iacobuzio-Donahue & Lovly will moderate the interactive Professional Advancement Session. https://t.co/czWFdzMpc4 @ciacobu @christine_lovly #AACR25 https://t.co/Wkvxs9HG4Y
-
-
Mashup Score: 12025 Professional Development Session “Productive Peer Review: Improving Science while Avoiding Common Pitfalls” Registration - 3 month(s) ago
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Source: www.surveymonkey.comCategories: General Medicine NewsTweet-
Attending the @AACR Annual Meeting? Register for “Productive Peer Review: Improving Science while Avoiding Pitfalls” on 4/28. Drs. Iacobuzio-Donahue & Lovly will moderate the interactive Professional Advancement Session. https://t.co/czWFdzMpc4 @ciacobu @christine_lovly #AACR25 https://t.co/Wkvxs9HG4Y
-
-
Mashup Score: 9Cancer Discovery | American Association for Cancer Research - 3 month(s) ago
Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to epidemiologic studies. The journal also publishes News and Research Watch sections. Read More About the Journal Lewis C. Cantley Luis A. Diaz The Twitter live feed is not currently active. This site uses cookies. By continuing to use our website, you are agreeing to our privacy
Source: aacrjournals.orgCategories: General Medicine News, Onc News and JournalsTweet-
Are you attending #CEI2024Symp? If you’d like to talk about your research or have questions about publishing in Cancer Discovery, please reach out to Associate Editor @DrBaileeSliker, PhD, during or after the meeting. https://t.co/OWq2CSMIdD @CeiFccc https://t.co/QuFmE8NVCw https://t.co/ElxDjryX3l
-
Stay up to date by signing up for Cancer Discovery News Alerts: https://t.co/DG8VFp6ztu https://t.co/sAkLqXkrmH